Market Overview:
The global targeted delivery drugs market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in drug delivery devices. Based on type, the global targeted delivery drugs market is segmented into ocular drug delivery, pulmonary drug delivery, and other types. Ocular drug delivery is further sub-segmented into topical ophthalmic drugs and injectable ophthalmic drugs. Topical ophthalmic drugs are those that are applied directly onto the eye surface or eyelids, while injectable ophthalmic drugs are administered as an injection into either the vitreous humor or anterior chamber of the eye. Pulmonary drug delivery is further sub-segmented into inhalation therapies and nebulization therapies. Inhalation therapies involve delivering medications directly to the lungs through an inhaler or nebulizer device, while nebulization therapies involve converting medications into a mist that can be inhaled by patients suffering from respiratory conditions such as asthma or COPD (chronic obstructive pulmonary disease). Other types include transdermal patches and oral transmucosal films/lozenges/gels/tablets etc., which are used for systemic absorption of therapeutic agents across mucosal membranes in various parts of body including mouth & throat region etc.
Product Definition:
Targeted Delivery Drugs are drugs that are designed to provide a more specific and efficient delivery to the target cells, tissues or organs. This is important because it can help reduce side effects and improve the effectiveness of the drug.
Ocular Drug Delivery:
Ocular drug delivery is the process of transporting drugs to the site of action in the eye. The most commonly used route for ocular drug delivery is by oral route; however, other routes such as transdermal, intravenous and subconjunctival are also employed. Ocular drug delivery has been a significant area of research and development over recent years with constant improvements being made in terms of technology.
Pulmonary Drug Delivery:
Pulmonary drug delivery is the process of transporting drugs to lung tissue by using pulmonary route of administration. Pulmonary route of administration is defined as the distribution and pulmonary clearance (PDC) of a drug from the site of application via airway, lungs, and alveolar sacs. The most commonly employed methods for pulmonary drug delivery include inhalation therapy and nebulization.
Application Insights:
Based on the application, the market is segmented into hospital, clinic and other. The other applications include home healthcare, urgent care center and others. Targeted delivery drugs are widely used in clinics as they offer benefits such as precise dosing with reduced side effects compared to conventional oral medication or injection methods.
The growing use of targeted drug delivery systems in hospitals for a variety of conditions including cancer is expected to drive demand over the forecast period. In addition, increasing R&D activities pertaining to new drug formulations that can be delivered via catheters are likely to propel growth during the study period.
On basis of type, targeted drug delivery devices are bifurcated into ocular drug delivery system (ODS), pulmonary device-based therapy ODSs.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to presence of key players, favorable reimbursement policies, and increasing R&D activities. In addition, rising prevalence of target diseases is anticipated to drive regional growth over the forecast period. For instance, COPD affects around 6 million people in U.S.
Asia Pacific also holds a significant share owing to growing healthcare expenditure.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyle and dietary habits of people across the world. The incidence of chronic diseases such as cancer, diabetes, and heart disease is on the rise, which is expected to drive the demand for targeted delivery drugs in the coming years.
- Advances in nanotechnology: Nanotechnology has revolutionized drug delivery by providing a platform for developing novel targeted delivery drugs. With advances in this field, it has become possible to target specific cells and tissues with great precision using nanoparticles. This is expected to boost the demand for targeted delivery drugs in the near future.
- Growing awareness about personalized medicine: There is growing awareness among people about personalized medicine – a branch of medicine that involves tailoring treatment according to individual genetic makeup or lifestyle factors. This trend is likely to fuel demand for targeted delivery drugs in the coming years as they are specifically designed to target individual patients based on their unique characteristics..
Scope Of The Report
Report Attributes
Report Details
Report Title
Targeted Delivery Drugs Market Research Report
By Type
Ocular Drug Delivery, Pulmonary Drug Delivery, Drug Eluting Stents, Other
By Application
Hospital, Clinic, Other
By Companies
Adverum, Arrowhead Pharmaceuticals, Bayer, Windtree Therapeutics, Immunocore, Mankind Pharma, Roche, Ra Pharma, Keystone Nano, Lipocine, MultiVir
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Targeted Delivery Drugs Market Report Segments:
The global Targeted Delivery Drugs market is segmented on the basis of:
Types
Ocular Drug Delivery, Pulmonary Drug Delivery, Drug Eluting Stents, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Adverum
- Arrowhead Pharmaceuticals
- Bayer
- Windtree Therapeutics
- Immunocore
- Mankind Pharma
- Roche
- Ra Pharma
- Keystone Nano
- Lipocine
- MultiVir
Highlights of The Targeted Delivery Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ocular Drug Delivery
- Pulmonary Drug Delivery
- Drug Eluting Stents
- Other
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Targeted Delivery Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Targeted delivery drugs are medications that are specifically designed to travel directly to the site of a disease or injury. This allows for faster and more effective treatment, as well as reduced side effects.
Some of the major players in the targeted delivery drugs market are Adverum, Arrowhead Pharmaceuticals, Bayer, Windtree Therapeutics, Immunocore, Mankind Pharma, Roche, Ra Pharma, Keystone Nano, Lipocine, MultiVir.
The targeted delivery drugs market is expected to register a CAGR of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Targeted Delivery Drugs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Targeted Delivery Drugs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Targeted Delivery Drugs Market - Supply Chain
4.5. Global Targeted Delivery Drugs Market Forecast
4.5.1. Targeted Delivery Drugs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Targeted Delivery Drugs Market Size (000 Units) and Y-o-Y Growth
4.5.3. Targeted Delivery Drugs Market Absolute $ Opportunity
5. Global Targeted Delivery Drugs Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Targeted Delivery Drugs Market Size and Volume Forecast by Type
5.3.1. Ocular Drug Delivery
5.3.2. Pulmonary Drug Delivery
5.3.3. Drug Eluting Stents
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Targeted Delivery Drugs Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Targeted Delivery Drugs Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Targeted Delivery Drugs Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Targeted Delivery Drugs Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Targeted Delivery Drugs Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Targeted Delivery Drugs Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Targeted Delivery Drugs Demand Share Forecast, 2019-2026
9. North America Targeted Delivery Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Targeted Delivery Drugs Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Targeted Delivery Drugs Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Targeted Delivery Drugs Market Size and Volume Forecast by Type
9.7.1. Ocular Drug Delivery
9.7.2. Pulmonary Drug Delivery
9.7.3. Drug Eluting Stents
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Targeted Delivery Drugs Demand Share Forecast, 2019-2026
10. Latin America Targeted Delivery Drugs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Targeted Delivery Drugs Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Targeted Delivery Drugs Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Targeted Delivery Drugs Market Size and Volume Forecast by Type
10.7.1. Ocular Drug Delivery
10.7.2. Pulmonary Drug Delivery
10.7.3. Drug Eluting Stents
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Targeted Delivery Drugs Demand Share Forecast, 2019-2026
11. Europe Targeted Delivery Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Targeted Delivery Drugs Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Targeted Delivery Drugs Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Targeted Delivery Drugs Market Size and Volume Forecast by Type
11.7.1. Ocular Drug Delivery
11.7.2. Pulmonary Drug Delivery
11.7.3. Drug Eluting Stents
11.7.4. Other
11.8. Basis Point Shar (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Targeted Delivery Drugs Demand Share, 2019-2026
12. Asia Pacific Targeted Delivery Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Targeted Delivery Drugs Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Targeted Delivery Drugs Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Targeted Delivery Drugs Market Size and Volume Forecast by Type
12.7.1. Ocular Drug Delivery
12.7.2. Pulmonary Drug Delivery
12.7.3. Drug Eluting Stents
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Targeted Delivery Drugs Demand Share, 2019-2026
13. Middle East & Africa Targeted Delivery Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Targeted Delivery Drugs Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Targeted Delivery Drugs Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Targeted Delivery Drugs Market Size and Volume Forecast by Type
13.7.1. Ocular Drug Delivery
13.7.2. Pulmonary Drug Delivery
13.7.3. Drug Eluting Stents
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Targeted Delivery Drugs Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Targeted Delivery Drugs Market: Market Share Analysis
14.2. Targeted Delivery Drugs Distributors and Customers
14.3. Targeted Delivery Drugs Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Adverum
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Arrowhead Pharmaceuticals
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bayer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Windtree Therapeutics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Immunocore
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Mankind Pharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Roche
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Ra Pharma
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Keystone Nano
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Lipocine
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. MultiVir
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
